Promiscuity in the geometry of electrostatic interactions between the Escherichia coli multidrug resistance transporter MdfA and cationic substrates

被引:43
作者
Adler, J [1 ]
Bibi, E [1 ]
机构
[1] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
关键词
D O I
10.1074/jbc.M412332200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Escherichia coli multidrug transporter MdfA contains a single membrane-embedded charged residue (Glu-26) that plays a critical role in the recognition of cationic substrates (Edgar, M, and Bibi, E. (1999) EMBO J. 18, 822-832). Using an inactive mutant (MdfA-E26T), we isolated a spontaneous second-site mutation (MdfA-E26T/V335E) that re-established the recognition of cationic drugs by the transporter. Only a negative charge at position 335 was able to restore the functioning of the inactive mutant MdfA-E26T. Intriguingly, the two genetically interacting residues are located at remote and distinct regions along the secondary structure of MdfA. Glu-26 is located in the periplasmic half of transmembrane helix 1, and as shown here, the complementing charge at position 335 resides within the cytoplasmic loop connecting transmembrane helices 10 and 11. The spatial relation between the two residues was investigated by cross-linking. A functional split version of MdfA devoid of cysteines was constructed and introduced with a cysteine pair at positions 26 and 335. Strikingly, the results indicate that residues 26 and 335 are spatially adjacent, suggesting that they both constitute parts of the multidrug recognition pocket of MdfA. The fact that electrostatic interactions are preserved with cationic substrates even if the critical acidic residue is placed on another face of the pocket reveals an additional dimension of promiscuity in multidrug recognition and transport.
引用
收藏
页码:2721 / 2729
页数:9
相关论文
共 53 条
[41]   SITE-SPECIFICITY OF THE SECOND-SITE SUPPRESSOR MUTATION OF THE ASP-285-]ASN MUTANT OF METAL-TETRACYCLINE/H+ ANTIPORTER OF ESCHERICHIA-COLI AND THE EFFECTS OF AMINO-ACID SUBSTITUTIONS AT THE FIRST AND 2ND SITES [J].
SOMEYA, Y ;
NIWA, A ;
SAWAI, T ;
YAMAGUCHI, A .
BIOCHEMISTRY, 1995, 34 (01) :7-12
[42]   Mechanism of ligand recognition by BmrR, the multidrug-responding transcriptional regulator:: Mutational analysis of the ligand-binding site [J].
Vázquez-Laslop, N ;
Markham, PN ;
Neyfakh, AA .
BIOCHEMISTRY, 1999, 38 (51) :16925-16931
[43]   Helix packing in the lactose permease of Escherichia coli determined by site-directed thiol cross-linking:: Helix I is close to helices V and XI [J].
Wang, QD ;
Kaback, HR .
BIOCHEMISTRY, 1999, 38 (10) :3120-3126
[44]   The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity [J].
Watkins, RE ;
Wisely, GB ;
Moore, LB ;
Collins, JL ;
Lambert, MH ;
Williams, SP ;
Willson, TM ;
Kliewer, SA ;
Redinbo, MR .
SCIENCE, 2001, 292 (5525) :2329-2333
[45]   GLY113-]ASP CAN RESTORE ACTIVITY TO THE ASP51-]SER MUTANT IN THE MELIBIOSE CARRIER OF ESCHERICHIA-COLI [J].
WILSON, DM ;
HAMA, H ;
WILSON, TH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 209 (01) :242-249
[46]   Helix proximity and ligand-induced conformational changes in the lactose permease of Escherichia coli determined by site-directed chemical crosslinking [J].
Wu, JH ;
Kaback, HR .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 270 (02) :285-293
[47]  
YAMAGUCHI A, 1993, J BIOL CHEM, V268, P26990
[48]   An essential glutamyl residue in EmrE, a multidrug antiporter from Escherichia coli [J].
Yerushalmi, H ;
Schuldiner, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) :5264-5269
[49]   Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump [J].
Yu, EW ;
McDermott, G ;
Zgurskaya, HI ;
Nikaido, H ;
Koshland, DE .
SCIENCE, 2003, 300 (5621) :976-980
[50]   A GENERAL-METHOD FOR MAPPING TERTIARY CONTACTS BETWEEN AMINO-ACID-RESIDUES IN MEMBRANE-EMBEDDED PROTEINS [J].
YU, HB ;
KONO, M ;
MCKEE, TD ;
OPRIAN, DD .
BIOCHEMISTRY, 1995, 34 (46) :14963-14969